Therapeutic Asset Ratings
271 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Survaxm
Gliosarcoma
Roswell Park Cancer Institute
P2
CCC
(53)
Survaxm
Lung Neuroendocrine Neoplasm
Roswell Park Cancer Institute
P2
CCC
(53)
Survaxm
Cancer
Roswell Park Cancer Institute
P2
CCC
(53)
Survaxm
Pancreatic Neuroendocrine Neoplasm
Roswell Park Cancer Institute
P2
CCC
(53)
TAMOXIFEN
Triple-Negative Breast Carcinoma
Roswell Park Cancer Institute
P2
CCC
(53)
CDX 1140
Primary Peritoneal Carcinoma
Roswell Park Cancer Institute
P2
CCC
(52)
Rintatolimod
Colorectal Carcinoma
Roswell Park Cancer Institute
P2
CCC
(52)
TEONANACATL
Cancer
Roswell Park Cancer Institute
P2
CCC
(52)
Decitabine
Fallopian Tube Carcinoma
Roswell Park Cancer Institute
P1/2
CCC
(52)
Decitabine
Prostate Cancer
Roswell Park Cancer Institute
P1/2
CCC
(52)
Acetylsalicylic Acid
Prostate Adenocarcinoma
Roswell Park Cancer Institute
P2
CCC
(51)
Binimetinib
Cancer
Roswell Park Cancer Institute
P2
CCC
(51)
CDX 1140
Ovarian Clear Cell Adenocarcinoma
Roswell Park Cancer Institute
P2
CCC
(51)
CDX 1140
Ovarian Carcinoma
Roswell Park Cancer Institute
P2
CCC
(51)
CDX 1140
Endometrial Serous Adenocarcinoma
Roswell Park Cancer Institute
P2
CCC
(51)
CDX 1140
Fallopian Tube Carcinoma
Roswell Park Cancer Institute
P2
CCC
(51)
CDX 1140
Fallopian Tube Endometrioid Adenocarcinoma
Roswell Park Cancer Institute
P2
CCC
(51)
CDX 1140
Fallopian Tube Serous Adenocarcinoma
Roswell Park Cancer Institute
P2
CCC
(51)
CDX 1140
Ovarian Endometrioid Adenocarcinoma
Roswell Park Cancer Institute
P2
CCC
(51)
CDX 1140
Ovarian Serous Adenocarcinoma
Roswell Park Cancer Institute
P2
CCC
(51)
CDX 1140
Recurrent Primary Peritoneal Endometrioid Adenocarcinoma
Roswell Park Cancer Institute
P2
CCC
(51)
CDX 1140
Primary Peritoneal Serous Adenocarcinoma
Roswell Park Cancer Institute
P2
CCC
(51)
INTERFERON ALFA-2B
Prostate Adenocarcinoma
Roswell Park Cancer Institute
P2
CCC
(51)
Decitabine
Metastatic Melanoma
Roswell Park Cancer Institute
P1/2
CCC
(51)
Rintatolimod
Colorectal Carcinoma
Roswell Park Cancer Institute
P2
CCC
(50)
Showing 151 to 175 of 271 assets
Previous
Page 7 of 11
Next